New Federal Laws Restricting Data Transfers to Foreign Adversaries: Scope, Enforcement, Penalties, Implications
Recording of a 90-minute CLE video webinar with Q&A
This CLE webinar will provide an overview of recent legislation and an Executive Order (EO) restricting the sale or release of sensitive data to foreign adversaries. The panelist will discuss the scope, applicability, and practical implications of these new laws and will provide guidance on actions companies need to take now to ensure compliance.
Outline
- Overview: current federal landscape regarding data use practices
- EO on Preventing Access To Americans' Bulk Sensitive Personal Data and U.S. Government-Related Data by Countries of Concern
- Protecting Americans' Data From Foreign Adversaries Act of 2024
- Protecting Americans From Foreign Adversary Controlled Applications Act
- Key definitions and provisions of new laws
- Scope and applicability
- Penalties for violations
- Implementation of new laws
- Harmonizing the new laws with current state laws regulating data brokers
- Implications for businesses
- Actions businesses need to take now to ensure compliance
Benefits
The panelist will discuss these and other key issues:
- What are the key definitions and provisions of the new legislation and EO prohibiting certain data transfers to foreign adversaries?
- What are the practical implications of these new laws for businesses?
- How will these new laws be enforced and what are the penalties for violations?
- When do these new laws become effective and what actions do businesses need to take now to ensure compliance?
Faculty
David Peloquin
Partner
Ropes & Gray
Mr. Peloquin advises clients on a wide range of legal and regulatory issues in the area of clinical research and... | Read More
Mr. Peloquin advises clients on a wide range of legal and regulatory issues in the area of clinical research and related activities. He counsels academic medical centers, life sciences companies, information technology companies and other clients that sponsor, support and conduct research. With a broad client base and knowledge of a range of laws and regulations, from the Common Rule and FDA regulations, to HIPAA and GDPR, to state and federal fraud and abuse laws—Mr. Peloquin offers clients clear, practical advice on how the complex legal landscape intersects with an array of research activities. In addition to his advisory work, Mr. Peloquin collaborates with the private equity group to conduct regulatory diligence of clinical research investments and works with the firm’s litigation practice on government and civil investigations involving clinical research. He speaks and writes frequently on issues in healthcare law and data privacy.
Close